Abstract:AcrB is the inner-membrane transporter of E. coli AcrAB-TolC tripartite efflux complex, which plays a major role in the intrinsic resistance to clinically important antibiotics. AcrB pumps a wide range of toxic substrates by utilizing the proton gradient between periplasm and cytoplasm. Crystal structures of AcrB revealed three distinct conformational states of the transport cycle, substrate access, binding and extrusion, or loose (L), tight (T) and open (O) states. However, the specific residue(s) responsible for proton binding/release and the mechanism of proton-coupled conformational cycling remain controversial. Here we use the newly developed membrane hybrid-solvent continuous constant pH molecular dynamics technique to explore the protonation states and conformational dynamics of the transmembrane domain of AcrB. Simulations show that both Asp407 and Asp408 are deprotonated in the L/T states, while only Asp408 is protonated in the O state. Remarkably, release of a proton from Asp408 in the O state results in large conformational changes, such as the lateral and vertical movement of transmembrane helices as well as the salt-bridge formation between Asp408 and Lys940 and other sidechain rearrangements among essential residues.Consistent with the crystallographic differences between the O and L protomers, simulations offer dynamic details of how proton release drives the O-to-L transition in AcrB and address the controversy regarding the proton/drug stoichiometry. This work offers a significant step towards characterizing the complete cycle of proton-coupled drug transport in AcrB and further validates the membrane hybrid-solvent CpHMD technique for studies of proton-coupled transmembrane proteins which are currently poorly understood.

Proton-coupled transport mechanism of the efflux pump NorA

NorA Functions As a Multidrug Efflux Protein in Both Cytoplasmic Membrane Vesicles and Reconstituted Proteoliposomes

Structural basis for inhibition of the drug efflux pump NorA from Staphylococcus aureus

Dynamics underlie the drug recognition mechanism by the efflux transporter EmrE

An Allosteric Transport Mechanism for the Acrab-Tolc Multidrug Efflux Pump

The Pseudo-Atomic Structure of an RND-type Tripartite Multidrug Efflux Pump.

Specificity and tunability of efflux pumps: a new role for the proton gradient?

Structure of the AcrAB–TolC Multidrug Efflux Pump

The production of group O cells.

Constant Ph Molecular Dynamics Reveals How Proton Release Drives the Conformational Transition of a Transmembrane Efflux Pump.

Mg2+-dependent mechanism of environmental versatility in a multidrug efflux pump

High-pH structure of EmrE reveals the mechanism of proton-coupled substrate transport

Effect of palladium(II) complexes on NorA efflux pump inhibition and resensitization of fluoroquinolone-resistant Staphylococcus aureus: in vitro and in silico approach

Na + -NQR Confers Aminoglycoside Resistance via the Regulation of l- Alanine Metabolism

Allosteric drug transport mechanism of multidrug transporter AcrB

Structures and Efflux Mechanisms of the AcrAB-TolC Pump

Conformational plasticity across phylogenetic clusters of RND multidrug efflux pumps and its impact on substrate specificity

A flexible cation binding site in the multidrug major facilitator superfamily transporter LmrP is associated with variable proton coupling

Mechanism of pH-dependent activation of the sodium-proton antiporter NhaA

Visualizing the nonlinear changes of a drug-proton antiporter from inward-open to occluded state

Bicaudate infarcts in the setting of congenital absence of A1 segment.